PanGenomic Health Inc. announced changes to its board of directors. The Company announced the resignation of Vincent Lum as a director of the Company. Mr. Lum, the previous CEO and a co-founder of PanGenomic Health, will continue to serve as the CEO, President, Executive Chair and a director of the Company's subsidiary, MUJN Diagnostics Inc. The Company is pleased to announced the appointment of Francisco Kent Carasquero as a director of the Company.

Mr. Carasquero previously served as the VP Finance and a director of the Company and has acted as a corporate finance consultant to the Company since its listing on the Canadian Securities Exchange.